Today a large group of Indian companies will release their quarterly numbers, and more will follow tomorrow. Below is a simple roundup of the most important results and business moves that everyday investors should know.
Quarterly Earnings Snapshot
Infosys
- Revenue rose 8.9% to ₹45,479 crore (about $5.1 bn), up 3.2% in dollar terms.
- Net profit slipped 2.2% to ₹6,654 crore.
- EBIT increased 6.4% to ₹9,479 crore, but the EBIT margin fell to 20.8% from 21.3%.
- FY26 guidance: constant‑currency revenue growth of 3‑3.5% (up from 2‑3%) and EBIT margin target of 20‑22%.
Jio Financial Services
- Profit dropped 8.75% to ₹268.98 crore.
- Total income surged 10.7% to ₹901.05 crore.
- Pre‑provision operating profit rose 7% to ₹354 crore.
- NBFC assets under management jumped 4.5× to ₹19,049 crore.
ICICI Prudential Asset Management
- Profit climbed 45.1% to ₹917.1 crore.
- Revenue grew 23.5% to ₹1,514.7 crore.
- Board approved an interim dividend of ₹14.85 per share.
HDB Financial Services
- Profit up 36.3% to ₹643.9 crore.
- Revenue increased 22% to ₹2,285 crore.
L&T Technology Services
- Profit fell 6.1% to ₹302.6 crore.
- Revenue grew 10.2% to ₹2,923.5 crore.
- Labour‑code impact recorded at ₹35.4 crore.
Nuvoco Vistas Corp
- Turned to a profit of ₹49 crore after a loss of ₹61.4 crore last year.
- Revenue rose 12.1% to ₹2,701.3 crore.
Angel One
- Profit slipped 4.5% to ₹268.7 crore.
- Revenue grew 5.8% to ₹1,334.9 crore.
- Board approved a 1:10 stock split and an interim dividend of ₹23 per share.
360 ONE WAM
- Profit jumped 20.3% to ₹331 crore.
- Revenue surged 33.2% to ₹806 crore.
South Indian Bank (Standalone)
- Profit rose 9.5% to ₹374.3 crore.
- Net interest income up 1.3% to ₹880.7 crore.
- Gross NPA fell to 2.67% from 2.93%; Net NPA improved to 0.45% from 0.56%.
Business Updates & Key Deals
- Biocon raised ₹4,150 crore through a Qualified Institutions Placement to fund the buy‑back of Mylan’s stake in Biocon Biologics.
- Zydus Lifesciences received US FDA approval for Eltrombopag tablets and completed the acquisition of Agenus’s biologics plant.
- Dr Reddy's launched an over‑the‑counter eye‑drop (Olopatadine) in the U.S., approved by the FDA.
- RailTel got a ₹88.66 crore order from Central Railway to set up IP‑MPLS network equipment across several divisions.
- NBCC secured a ₹55.02 crore contract from Indian Overseas Bank for designing and constructing its new regional office in Raipur.
- Sun Pharma Advanced Research approved 3.85 crore warrants worth ₹599.98 crore for promoter group Shanghvi Finance.
- BHEL started supplying semi‑high‑speed traction transformers for the Vande Bharat Sleeper Train project.
- NTPC Green Energy and GAIL signed a 50:50 joint‑venture agreement to develop renewable‑energy projects.
- Godrej Properties reported a 19% YoY rise in booking value to ₹34,171 crore for FY 2025, with collections up 28%.
- Shriram Finance obtained shareholder approval for a strategic capital infusion from MUFG Bank and a one‑time payment to its promoter.
- NITCO appointed Bikash Jain as CFO, effective 16 Jan.
- TVS Supply Chain Solutions named Vikas Chadha as Global CEO, starting 22 Jan.
- DLF received NCLT approval to merge with its 16 wholly‑owned subsidiaries on 1 Apr 2024.
- Apeejay Surrendra Park Hotels opened its first hotel in Bihar – Zone Connect by The Park, Patna.
- Zaggle signed a referral agreement with Jio Credit for device‑leasing solutions.
- Transrail Lighting secured orders worth ₹527 crore in the MENA and Africa regions, taking FY26 order inflow to ₹5,637 crore.
Bulk Deal Activity
- Aavas Financiers: Small Cap World Fund sold its 2.48% stake (19.64 lakh shares) for ₹1,440 per share; HDFC Mutual Fund bought a similar 2.46% stake at the same price.
- IndiaMART InterMESH: Smallcap World Fund sold 1.04% stake (6.26 lakh shares) for ₹132.17 crore; Nalanda India Equity Fund bought 1.86% (11.18 lakh shares) for ₹236.05 crore at ₹2,110 per share.
- Polycab India: Motilal Oswal Mutual Fund sold 0.5% stake (7.61 lakh shares) at ₹7,350.02 per share, amounting to ₹559.4 crore.
Stocks Trading Ex‑Dividends / Ex‑Dates
- Tata Consultancy Services
- HCL Technologies
- Jaro Institute of Technology Management and Research
- TAAL Tech
Disclaimer
Remember, this is just a summary and not a recommendation. Always do your own research or consult a financial advisor before making any investment decisions.